서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 12 of 12

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2006-08	First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma Lee, Keun-Wook; Yun, Tak; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Yoon, Sung-Soo; Heo, Dae Seog; Bang, Yung-Jue; Park, Seonyang; Kim, Byoung Kook; Kim, Noe Kyeong Leuk Lymphoma. 2006 Jul;47(7):1274-82.	link
2007-05	Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer Lee, Keun Seok; Chung, Hyun Cheol; Im, Seock Ah; Park, Yeon Hee; Kim, Chul Soo; Kim, Sung-Bae; Rha, Sun Young; Lee, Min Young; Ro, Jungsil Breast Cancer Res Treat. 2008 ;108(2):241-50.	DOI
2007-06	Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy Jung, Yeonjoo; Park, Jinah; Kim, Tai Young; Park, Jung-Hyun; Jong, Hyun-Soon; Im, Seock-Ah; Robertson, Keith D; Bang, Yung-Jue; Kim, Tae-You J Mol Med. 2007 Oct;85(10):1137-48. Epub 2007 Jun 15.	link
2008-12	Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W Jpn J Clin Oncol. 2009 Feb;39(2):111-5. Epub 2008 Dec 5.	link
2009-01	Neoadjuvant Chemotherapy Followed by Limited Surgery in a Mouse Model of Head and Neck Cancer Lee, Jae Jin; Hah, Jeong-Hun; Im, Seock-Ah; Kim, Si-Young; Kim, Kwang Hyun; Heo, Dae Soeg; Sung, Myung-Whun ANTICANCER RESEARCH; Vol.29 1; 255-259
2009-01	Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study Lee, Jeeyun; Jung, Kyung Hae; Park, Young Suk; Ahn, Joong Bae; Shin, Sang Jun; Im, Seock-Ah; Oh, Do Youn; Shin, Dong Bok; Kim, Tae Won; Lee, Namsu; Byun, Jae Ho; Hong, Yong Sang; Park, Joon Oh; Park, Se Hoon; Lim, Ho Yeong; Kang, Won Ki Cancer Chemother Pharmacol. 2009 Sep;64(4):657-63. Epub 2009 Jan 24.	link
2010-07	Is Duodenal Invasion a Relevant Prognosticator in Patients Undergoing Adjuvant Chemoradiotherapy for Distal Common Bile Duct Cancer? Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. International Journal of Radiation Oncology Biology Physics, Vol.77 No.4, pp.1186-1190	DOI
2010-12	Combination Chemotherapy with S-1 and Platinum in Advanced Hepatocellular Carcinoma Kim, Su-Jung; Han, Sae-Won; Oh, Do-Youn; Yi, Nam-Joon; Im, Seock-Ah; Kang, Gyeong Hoon; Bang, Yung-Jue; Kim, Tae-You; Jang, Ja-Joon; Suh, Kyung Suk; Yoon, Jung-Hwan; Kim, Yoon Jun ANTICANCER RESEARCH; Vol.30 12; 5245-5250
2011-05	Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancer Kim, Kyubo; Chie, Eui Kyu; Han, Wonshik; Noh, Dong-Young; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W. Tumori, Vol.97 No.3, pp.280-285	DOI
2013-12	The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer Lee, Joo Ho; Chie, Eui Kyu; Kim, Kyubo; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kang, Gyeong Hoon; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W BMC Cancer Vol.13, pp. 1-9	view file link
2020-10	Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer Lee, Kyung-Hun; Chie, Eui Kyu; Im, Seock-Ah; Kim, Jee Hyun; Kwon, Jihyun; Han, Sae-Won; Oh, Do-Youn; Jang, Jin-Young; Kim, Jae-Sung; Kim, Tae-You; Bang, Yung-Jue; Kim, Sun Whe; Ha, Sung W. Cancer Research and Treatment, Vol.53 No.4, pp.1096-1103	DOI
2021-01	A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer Schmid, Peter; Sablin, Marie-Paule; Bergh, Jonas; Im, Seock-Ah; Lu, Yen-Shen; Martínez, Noelia; Neven, Patrick; Lee, Keun Seok; Morales, Serafín; Pérez-Fidalgo, J. A; Adamson, Douglas; Gonçalves, Anthony; Prat, Aleix; Jerusalem, Guy; Schlieker, Laura; Espadero, Rosa-Maria; Bogenrieder, Thomas; Huang, Dennis C; Crown, John; Cortés, Javier Breast Cancer Research. 2021 Jan 15;23(1):8	view file DOI

1